Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
2024-09-16 Purchase | 2024-09-17 8:28 pm | MBX Biosciences Inc. | MBX | Mathers Edward T Director 10% Owner | 500,000 | $16 | $8,000,000 | 3,614,486 (Indirect) | View |
2024-04-22 Purchase | 2024-04-24 5:00 pm | Korro Bio Inc. | KRRO | Mathers Edward T 10% Owner | 17,857 | $56 | $999,992 | 1,090,793 (Indirect) | View |
2023-07-17 Purchase | 2023-07-19 7:10 pm | Savara Inc | SVRA | Mathers Edward T 10% Owner | 333,333 | $3 | $999,999 | 24,471,264 (Indirect) | View |
2021-06-28 Purchase | 2021-06-30 6:06 pm | Monte Rosa Therapeutics Inc. | GLUE | Mathers Edward T 10% Owner | 1,050,000 | $19 | $19,950,000 | 7,692,298 (Indirect) | View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
2024-09-16 Conversion | 2024-09-17 8:28 pm | N/A N/A | MBX Biosciences Inc. | MBX | Mathers Edward T Director 10% Owner | 40,557,180 | $0 | 3,614,486 (Indirect) | View |
2024-09-12 Option Award | 2024-09-13 5:11 pm | N/A 2034-09-11 | MBX Biosciences Inc. | MBX | Mathers Edward T Director 10% Owner | 15,963 | $0 | 15,963 (Direct) | View |
Ownership | 2024-09-12 7:31 pm | N/A N/A | MBX Biosciences Inc. | MBX | Mathers Edward T Director 10% Owner | 0 | $0 | 3,114,486 (Indirect) | View |
2024-07-10 Option Award | 2024-07-12 4:30 pm | N/A 2034-07-09 | Senti Biosciences Inc. | SNTI | Mathers Edward T Director | 62,500 | $0 | 62,500 (Direct) | View |
2024-06-21 Exercise | 2024-06-25 4:38 pm | N/A N/A | RHYTHM PHARMACEUTICALS INC. | RYTM | Mathers Edward T Director | 3,000 | $0 | 8,771 (Direct) | View |
2024-06-18 Option Award | 2024-06-20 9:43 pm | N/A 2034-06-17 | RHYTHM PHARMACEUTICALS INC. | RYTM | Mathers Edward T Director | 18,000 | $0 | 18,000 (Direct) | View |
2024-06-18 Option Award | 2024-06-20 4:30 pm | N/A 2034-06-17 | Inozyme Pharma Inc. | INZY | Mathers Edward T Director | 28,000 | $0 | 28,000 (Direct) | View |
2024-06-13 Option Award | 2024-06-14 4:40 pm | N/A 2034-06-12 | Trevi Therapeutics Inc. | TRVI | Mathers Edward T Director | 30,000 | $0 | 30,000 (Direct) | View |
Ownership | 2023-11-07 9:31 pm | N/A N/A | Korro Bio Inc. | KRRO | Mathers Edward T 10% Owner | 0 | $0 | 1,072,936 (Indirect) | View |
2023-06-28 Option Award | 2023-06-30 4:14 pm | N/A 2033-06-27 | Trevi Therapeutics Inc. | TRVI | Mathers Edward T Director | 30,000 | $0 | 30,000 (Direct) | View |
2023-06-22 Option Award | 2023-06-26 3:46 pm | N/A 2033-06-22 | SYNLOGIC INC. | SYBX | Mathers Edward T Director | 30,000 | $0 | 30,000 (Direct) | View |
2023-06-21 Option Award | 2023-06-23 4:58 pm | N/A 2033-06-20 | RHYTHM PHARMACEUTICALS INC. | RYTM | Mathers Edward T Director | 17,000 | $0 | 17,000 (Direct) | View |
2023-06-16 Option Award | 2023-06-21 7:24 pm | N/A 2033-06-15 | Senti Biosciences Inc. | SNTI | Mathers Edward T Director | 62,500 | $0 | 62,500 (Direct) | View |
2023-06-13 Option Award | 2023-06-15 4:16 pm | N/A 2033-06-12 | Inozyme Pharma Inc. | INZY | Mathers Edward T Director | 16,000 | $0 | 16,000 (Direct) | View |
2023-06-06 Option Award | 2023-06-08 8:09 pm | N/A 2033-06-05 | Reneo Pharmaceuticals Inc. | RPHM | Mathers Edward T Director | 17,500 | $0 | 17,500 (Direct) | View |
2023-03-02 Other | 2023-03-06 1:47 pm | N/A N/A | RHYTHM PHARMACEUTICALS INC. | RYTM | Mathers Edward T Director | 5,771 | $0 | 11,542 (Indirect) | View |
Ownership | 2023-01-03 4:33 pm | N/A 2027-01-24 | ObsEva SA | OBSV | Mathers Edward T Director | 0 | $0 | 158,780 (Direct) | View |
2022-12-01 Disposition | 2022-12-02 5:09 pm | N/A 2032-06-22 | Akouos Inc. | AKUS | Mathers Edward T Director | 16,000 | $0 | 0 (Direct) | View |
2022-07-13 Option Award | 2022-07-15 6:09 pm | N/A 2032-07-12 | Senti Biosciences Inc. | SNTI | Mathers Edward T Director | 125,000 | $0 | 125,000 (Direct) | View |
2022-06-23 Option Award | 2022-06-27 5:08 pm | N/A 2032-06-22 | Akouos Inc. | AKUS | Mathers Edward T Director | 16,000 | $0 | 16,000 (Direct) | View |
2022-06-23 Option Award | 2022-06-23 5:04 pm | N/A 2032-06-22 | Trevi Therapeutics Inc. | TRVI | Mathers Edward T Director | 20,000 | $0 | 20,000 (Direct) | View |
2022-06-10 Option Award | 2022-06-14 4:32 pm | N/A 2032-06-09 | Inozyme Pharma Inc. | INZY | Mathers Edward T Director | 9,367 | $0 | 9,367 (Direct) | View |
2022-06-09 Option Award | 2022-06-13 4:45 pm | N/A 2032-06-09 | SYNLOGIC INC. | SYBX | Mathers Edward T Director | 27,000 | $0 | 27,000 (Direct) | View |
2022-06-08 Option Award | 2022-06-10 4:35 pm | N/A 2032-06-07 | RHYTHM PHARMACEUTICALS INC. | RYTM | Mathers Edward T Director | 20,000 | $0 | 20,000 (Direct) | View |
2022-06-02 Option Award | 2022-06-06 6:23 pm | N/A 2032-06-01 | Mirum Pharmaceuticals Inc. | MIRM | Mathers Edward T Director | 17,000 | $0 | 17,000 (Direct) | View |
2022-06-01 Option Award | 2022-06-03 5:26 pm | N/A 2032-05-31 | Reneo Pharmaceuticals Inc. | RPHM | Mathers Edward T Director | 17,500 | $0 | 17,500 (Direct) | View |
2022-04-11 Option Award | 2022-04-13 5:32 pm | N/A N/A | Trevi Therapeutics Inc. | TRVI | Mathers Edward T Director | 948,948 | $1.9 | 3,948,948 (Indirect) | View |
2022-04-11 Option Award | 2022-04-13 5:32 pm | N/A N/A | Trevi Therapeutics Inc. | TRVI | Mathers Edward T Director | 3,000,000 | $1.899 | 3,948,948 (Indirect) | View |
Ownership | 2022-01-05 6:05 pm | N/A N/A | Bright Health Group Inc. | BHG | Mathers Edward T 10% Owner | 0 | $0 | 67,952,892 (Indirect) | View |
2021-06-28 Conversion | 2021-06-30 6:06 pm | N/A N/A | Monte Rosa Therapeutics Inc. | GLUE | Mathers Edward T 10% Owner | 30,092,935 | $0 | 7,692,298 (Indirect) | View |
2021-06-24 Option Award | 2021-06-25 5:49 pm | N/A 2031-06-23 | Akouos Inc. | AKUS | Mathers Edward T Director | 16,000 | $0 | 16,000 (Direct) | View |